source
- Legend Biotech appoints former Novartis executive as CEO while Vera pursues full approval for kidney drugLegend Biotech announced that Ingrid Zhang, a former Novartis executive, will take over as chief executive officer, replacing Ying Huang who stepped down in July. Vera reported that its recently l…
- STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and moreGSK has continued its drive to bulk up its pipeline, taking global rights to a multiple myeloma treatment developed in China